Science
Mechanism of Action
Inhibits tyrosinase enzyme activity to prevent melanin synthesis while simultaneously activating PPARγ receptors to modulate inflammatory responses and promote healthy adipocyte differentiation. Additionally provides antioxidant protection and potential UVA filtering properties to combat photoaging damage.
Research
Clinical Evidence
Medium confidence0.5%
Key findings
- 01 Significant melanogenesis inhibition in B16F10 melanoma cells with minimal cytotoxicity
- 02 Effective topical treatment for viral lesions with reduced inflammation and healing time
Transparency
Dusting Analysis
Effective concentrations require 0.1% minimum based on clinical data; concentrations below 0.01% likely represent cosmetic dusting with minimal therapeutic benefit
The Formula
Formulation
Stability
Requires organic solvents or medium-chain triglycerides for proper dissolution. Stable in nanoemulsion systems at pH 5.0 or below; higher pH levels compromise stability and efficacy.
Synergies
- Medium-chain triglycerides
- Ethanol-based delivery systems
- Other tyrosinase inhibitors
Conflicts
- Strong oxidizing agents
- High pH formulations (>5.0)
- Water-only systems without solubilizers
Safety
Safety Profile
Classified as Skin and Eye Irritant Category 2 under GHS classification. In silico studies indicate potential for skin sensitization and phototoxicity at elevated concentrations.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Promising multi-functional brightening agent with solid research backing, though moderate irritancy limits use to non-sensitive skin types.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources